Spots Global Cancer Trial Database for anakinra
Every month we try and update this database with for anakinra cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Everolimus and Anakinra or Denosumab in Treating Participants With Relapsed or Refractory Advanced Cancers | NCT01624766 | Advanced Malign... Metastatic Mali... Recurrent Malig... Refractory Mali... | Anakinra Denosumab Everolimus | 18 Years - | M.D. Anderson Cancer Center | |
| A Study of Anakinra to Prevent or Treat Severe Side Effects for Patients Receiving CAR-T Cell Therapy | NCT04148430 | B Cell ALL B-Cell Lymphoma B-cell Non Hodg... | Anakinra | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Lenalidomide and Dexamethasone With or Without Anakinra in Treating Patients With Early Stage Multiple Myeloma | NCT02492750 | Indolent Plasma... Plasma Cell Mye... Smoldering Plas... | Anakinra Dexamethasone Laboratory Biom... Lenalidomide Placebo | 18 Years - | Mayo Clinic | |
| Anakinra: Efficacy in the Management of Fever During Neutropenia and Mucositis in ASCT - A Randomized Controlled Trial | NCT04099901 | Multiple Myelom... | Anakinra Placebos | 18 Years - | Radboud University Medical Center | |
| The SPECTRA Study | NCT00537667 | Rheumatoid Arth... | anakinra anakinra and PE... | 18 Years - | Swedish Orphan Biovitrum | |
| Anakinra: Efficacy in the Management of Fever During Neutropenia and Mucositis in ASCT - A Randomized Controlled Trial | NCT04099901 | Multiple Myelom... | Anakinra Placebos | 18 Years - | Radboud University Medical Center | |
| The SPECTRA Study | NCT00537667 | Rheumatoid Arth... | anakinra anakinra and PE... | 18 Years - | Swedish Orphan Biovitrum | |
| A Phase 2 Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity | NCT04150913 | Non Hodgkin Lym... Refractory Non-... Relapsed Non Ho... Neurotoxicity Neurotoxicity S... Cytokine Releas... | Anakinra Axicabtagene Ci... | 18 Years - | Massachusetts General Hospital | |
| Anakinra for the Prevention of Cytokine Release Syndrome and Neurotoxicity in Patients With B-Cell Non-Hodgkin Lymphoma Receiving CD19-Targeted CAR-T Cell Therapy | NCT04359784 | B-Cell Non-Hodg... | Anakinra X-Ray Imaging Positron Emissi... Computed Tomogr... Bone Marrow Asp... Bone Marrow Bio... Lumbar Puncture Biospecimen Col... | 18 Years - | Fred Hutchinson Cancer Center | |
| Lenalidomide and Dexamethasone With or Without Anakinra in Treating Patients With Early Stage Multiple Myeloma | NCT02492750 | Indolent Plasma... Plasma Cell Mye... Smoldering Plas... | Anakinra Dexamethasone Laboratory Biom... Lenalidomide Placebo | 18 Years - | Mayo Clinic | |
| A Pilot, Prospective, Non-randomized Evaluation of the Safety of Anakinra Plus Standard Chemotherapy | NCT02021422 | Pancreas Cancer | anakinra Oxaliplatin Irinotecan fluorouracil | 18 Years - | Baylor Research Institute | |
| Chemotherapy + Anakinra in Patients With Pancreatic Adenocarcinoma (PDAC) | NCT04926467 | Pancreatic Aden... | Anakinra | 18 Years - | Baylor Research Institute | |
| Anakinra for the Reduction of CAR-T Toxicity in Patients With Relapsed or Refractory Large B-cell Lymphoma | NCT04432506 | Hematopoietic a... Recurrent Diffu... Recurrent High ... Recurrent Prima... Recurrent Trans... Refractory Diff... Refractory High... Refractory Prim... Refractory Tran... | Anakinra Axicabtagene Ci... Cyclophosphamid... Fludarabine | 18 Years - | M.D. Anderson Cancer Center | |
| Gemcitabine, Nab-Paclitaxel, Cisplatin and Anakinra Treatment on Patients With Pancreatic Cancer | NCT02550327 | Pancreatic Aden... | Nab-paclitaxel Gemcitabine Cisplatin Anakinra | 18 Years - | Baylor Research Institute | |
| The SPECTRA Study | NCT00537667 | Rheumatoid Arth... | anakinra anakinra and PE... | 18 Years - | Swedish Orphan Biovitrum | |
| A Study of Anakinra to Prevent or Treat Severe Side Effects for Patients Receiving CAR-T Cell Therapy | NCT04148430 | B Cell ALL B-Cell Lymphoma B-cell Non Hodg... | Anakinra | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Anakinra in Preventing Severe Chimeric Antigen Receptor T-Cell Related Encephalopathy Syndrome in Patients With Recurrent or Refractory Large B-cell Lymphoma | NCT04205838 | Diffuse Large B... High Grade B-Ce... Progressive Dis... Recurrent Diffu... Recurrent High ... Recurrent Prima... Recurrent Trans... Refractory Diff... Refractory High... Refractory Prim... Refractory Tran... | Anakinra Axicabtagene Ci... Cyclophosphamid... Fludarabine Fludarabine Pho... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Chemotherapy + Anakinra in Patients With Pancreatic Adenocarcinoma (PDAC) | NCT04926467 | Pancreatic Aden... | Anakinra | 18 Years - | Baylor Research Institute | |
| Lenalidomide and Dexamethasone With or Without Anakinra in Treating Patients With Early Stage Multiple Myeloma | NCT02492750 | Indolent Plasma... Plasma Cell Mye... Smoldering Plas... | Anakinra Dexamethasone Laboratory Biom... Lenalidomide Placebo | 18 Years - | Mayo Clinic | |
| A Study of CART-PSMA-TGFβRDN in Patients With Metastatic Castration Resistant Prostate Cancer | NCT04227275 | Metastatic Cast... | CART-PSMA-TGFβR... Cyclophosphamid... Fludarabine Anakinra | 18 Years - | Tceleron Therapeutics, Inc. | |
| Safety and Blood Immune Cell Study of Anakinra Plus Physician's Chemotherapy Choice in Metastatic Breast Cancer Patients | NCT01802970 | Metastatic Brea... | Anakinra plus S... | 18 Years - 80 Years | Baylor Research Institute | |
| Study Evaluating the Influence of LV5FU2 Bevacizumab Plus Anakinra Association on Metastatic Colorectal Cancer | NCT02090101 | Metastatic Colo... | ANAKINRA | 18 Years - 80 Years | Centre Georges Francois Leclerc | |
| Anakinra in Preventing Severe Chimeric Antigen Receptor T-Cell Related Encephalopathy Syndrome in Patients With Recurrent or Refractory Large B-cell Lymphoma | NCT04205838 | Diffuse Large B... High Grade B-Ce... Progressive Dis... Recurrent Diffu... Recurrent High ... Recurrent Prima... Recurrent Trans... Refractory Diff... Refractory High... Refractory Prim... Refractory Tran... | Anakinra Axicabtagene Ci... Cyclophosphamid... Fludarabine Fludarabine Pho... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Anakinra in Preventing Severe Chimeric Antigen Receptor T-Cell Related Encephalopathy Syndrome in Patients With Recurrent or Refractory Large B-cell Lymphoma | NCT04205838 | Diffuse Large B... High Grade B-Ce... Progressive Dis... Recurrent Diffu... Recurrent High ... Recurrent Prima... Recurrent Trans... Refractory Diff... Refractory High... Refractory Prim... Refractory Tran... | Anakinra Axicabtagene Ci... Cyclophosphamid... Fludarabine Fludarabine Pho... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Anakinra: Safety and Efficacy in the Management of Fever During Neutropenia and Mucositis in ASCT | NCT03233776 | Multiple Myelom... | Anakinra | 18 Years - | Radboud University Medical Center | |
| A Study of CART-PSMA-TGFβRDN in Patients With Metastatic Castration Resistant Prostate Cancer | NCT04227275 | Metastatic Cast... | CART-PSMA-TGFβR... Cyclophosphamid... Fludarabine Anakinra | 18 Years - | Tceleron Therapeutics, Inc. | |
| Study Evaluating the Influence of LV5FU2 Bevacizumab Plus Anakinra Association on Metastatic Colorectal Cancer | NCT02090101 | Metastatic Colo... | ANAKINRA | 18 Years - 80 Years | Centre Georges Francois Leclerc | |
| Anakinra for the Reduction of CAR-T Toxicity in Patients With Relapsed or Refractory Large B-cell Lymphoma | NCT04432506 | Hematopoietic a... Recurrent Diffu... Recurrent High ... Recurrent Prima... Recurrent Trans... Refractory Diff... Refractory High... Refractory Prim... Refractory Tran... | Anakinra Axicabtagene Ci... Cyclophosphamid... Fludarabine | 18 Years - | M.D. Anderson Cancer Center | |
| Anakinra: Efficacy in the Management of Fever During Neutropenia and Mucositis in ASCT - A Randomized Controlled Trial | NCT04099901 | Multiple Myelom... | Anakinra Placebos | 18 Years - | Radboud University Medical Center | |
| Anakinra in Previously Untreated Chronic Lymphocytic Leukemia Patients | NCT04691765 | Chronic Lymphoc... | Kineret | 18 Years - | Sunnybrook Health Sciences Centre | |
| A Pilot, Prospective, Non-randomized Evaluation of the Safety of Anakinra Plus Standard Chemotherapy | NCT02021422 | Pancreas Cancer | anakinra Oxaliplatin Irinotecan fluorouracil | 18 Years - | Baylor Research Institute | |
| Study Evaluating the Influence of LV5FU2 Bevacizumab Plus Anakinra Association on Metastatic Colorectal Cancer | NCT02090101 | Metastatic Colo... | ANAKINRA | 18 Years - 80 Years | Centre Georges Francois Leclerc | |
| Anakinra in Treating Patients With Metastatic Cancer Expressing the Interleukin-1 Gene | NCT00072111 | Unspecified Adu... | anakinra | 18 Years - | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
